Home/Filings/4/0001600132-17-000112
4//SEC Filing

Luehring Jens 4

Accession 0001600132-17-000112

CIK 0001600132other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:06 PM ET

Size

6.8 KB

Accession

0001600132-17-000112

Insider Transaction Report

Form 4
Period: 2017-09-29
Luehring Jens
Director10% Owner
Transactions
  • Purchase

    Common Stock Warrants (right to buy)

    2017-09-29+10,00010,000 total
    Exercise: $1.24From: 2018-03-29Exp: 2022-09-29Common Stock (10,000 underlying)
  • Purchase

    Common Stock

    2017-09-29+10,00080,658 total
Footnotes (1)
  • [F1]The reported securities are included within Units purchased by the reporting person for $1.205 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1
  • filerCIK 0001631764

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:06 PM ET
Size
6.8 KB